Sponsors (2)
The bill strengthens U.S. oversight and formal athlete representation in international anti-doping governance to push for reforms and transparency, but it risks diplomatic friction, reduced influence if funding is withheld, and a shift of ONDCP resources away from domestic programs.
U.S. Olympic and Paralympic athletes gain a defined 'independent athlete' status and stronger push for formal decision-making roles on WADA bodies, increasing their representation in anti-doping governance.
ONDCP is required to review WADA governance within 90 days, increasing U.S. oversight and accountability of international anti-doping governance.
ONDCP may withhold U.S. dues to WADA if WADA fails to meet specified criteria, giving the U.S. leverage to press for anti-doping reforms.
Withholding U.S. dues could reduce U.S. influence within WADA and impair international coordination on anti-doping, potentially harming athletes who rely on global cooperation for fair competition.
Mandates to secure U.S. representation and to 'use all available tools' could provoke diplomatic friction with other countries and WADA stakeholders, complicating multilateral relations in sport.
Increased ONDCP oversight and reporting obligations may shift agency resources toward WADA governance work and away from domestic prevention and treatment programs.
Based on analysis of 2 sections of legislative text.
Introduced January 23, 2025 by John Moolenaar · Last progress January 23, 2025
Requires the Office of National Drug Control Policy (ONDCP) to assess whether the World Anti-Doping Agency (WADA) meets newly specified governance, reform, and athlete-representation standards and to take steps if it does not. Adds a new definition for “independent athlete,” directs ONDCP to consult with USADA, USOPC, and the Team USA Athletes’ Commission, allows ONDCP to withhold U.S. dues to WADA if criteria are unmet, and requires reporting and a spending plan to Appropriations Committees before obligating funds to WADA.